SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation

Publication date: January–February 2018 Source:The Journal of Allergy and Clinical Immunology: In Practice, Volume 6, Issue 1 Author(s): Katie D. White, Riichiro Abe, Michael Ardern-Jones, Thomas Beachkofsky, Charles Bouchard, Bruce Carleton, James Chodosh, Ricardo Cibotti, Robert Davis, Joshua C. Denny, Roni P. Dodiuk-Gad, Elizabeth N. Ergen, Jennifer L. Goldman, James H. Holmes, Shuen-Iu Hung, Mario E. Lacouture, Rannakoe J. Lehloenya, Simon Mallal, Teri A. Manolio, Robert G. Micheletti, Caroline M. Mitchell, Maja Mockenhaupt, David A. Ostrov, Rebecca Pavlos, Munir Pirmohamed, Elena Pope, Alec Redwood, Misha Rosenbach, Michael D. Rosenblum, Jean-Claude Roujeau, Arturo P. Saavedra, Hajirah N. Saeed, Jeffery P. Struewing, Hirohiko Sueki, Chonlaphat Sukasem, Cynthia Sung, Jason A. Trubiano, Jessica Weintraub, Lisa M. Wheatley, Kristina B. Williams, Brandon Worley, Wen-Hung Chung, Neil H. Shear, Elizabeth J. Phillips Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a life-threatening, immunologically mediated, and usually drug-induced disease with a high burden to individuals, their families, and society with an annual incidence of 1 to 5 per 1,000,000. To effect significant reduction in short- and long-term morbidity and mortality, and advance clinical care and research, coordination of multiple medical, surgical, behavioral, and basic scientific disciplines is required. On March 2, 2017, an investigator-driven me...
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research